Aspect to Consider in Fluid Therapy

Embed Size (px)

Citation preview

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    1/34

    Aspect to Consider in Fluid Therapy

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    2/34

    Fluid Therapy

    Resuscitation

    Maintenance fluid therapy

    Nutrition

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    3/34

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    4/34

    Resuscitation

    In Shockevery stage of shock

    Dehydration

    leeding urn

    !eakage syndro"ehypovole"ia

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    5/34

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    6/34

    Class I Class II Class III Class I#

    lood loss $p to %&' %&'()&'' )&''(*''' +*'''

    lood loss

    , -.#/

    $p to )&- )&(0'- 0'(1'- +1'-

    2ulse rate 3)'' +)'' +)*' +)1'

    loodpressure

    Nor"al Nor"al Decrease Decrease

    2ulse pressure Nor"al ordecrease

    Decrease Decrease Decrease

    Respiratoryrate

    )1(*' *'(0' 0'(0& +0&

    $rine output +0' *'(0' &()& No $4

    CNS5 "entalstatus

    Slightlyan6ious

    Mildly an6ious An6ious andconfused

    Confused andlethargic

    Fluidreplace"ent

    crystalloid crystalloid Crystalloid5colloid

    Crystallloid5colloid

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    7/34

    .sti"ated lood #olu"e

    Age lood #olu"e

    Neonate

    2re"ature 7&(8'5kg9Full(ter" 7& "l5:g9

    Infant 7' "l5:g9

    AdultMale %& "l5:g9

    Fe"ale ;& "l5:g9

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    8/34

    D4* < Cardiac Output6 Ca4* , arterial 4* content /

    ,=> 6Sp4* 6)?01 /@ , '?''0 6 2a4*/

    Stroke #ol 6 =R

    #olu"e 6 contractility

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    9/34

    Duration of fluid intravascular

    Type of fluid Duration in intravascular

    Al>u"in &- *(0 hour

    HES ( Hydroxy Ethyl Starch) 4-5 hour

    elatin , hae"acel? gelofusin/ )B& * hour

    De6tran )B& * hour

    Crystalloid )& *' "inute

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    10/34

    Colloids are superior to cristalloids at

    attaining resuscitation he"odyna"ic

    endpoint?

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    11/34

    9hat are the stakes

    Risks of inadeEuate resuscitation

    !ife(threatening

    Nonfatal

    Risks of e6cessive resuscitation

    !ife(threatening

    Nonfatal

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    12/34

    !ife(Threatening ConseEuences of

    InadeEuate Resuscitation

    !actic acidosis Acute renal failure

    Multisyste" organ failure

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    13/34

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    14/34

    Maintenance Fluid Support

    (2atient fasting ith nor"al >ody fluid

    co"position

    ( Critically ill patients ith altered >odyfluid co"position

    ( 2erioperative losses , 2reoperative?

    during the operation? postoperatively/

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    15/34

    asic 2rinciples of Fluid Maintenance

    Therapy

    Replace

    Maintenance

    Repair

    A>nor"al lossG IT? 0rdspace?

    4ngoing loss? septic and

    =ypovole"ic shock

    I9! @ urine

    Acid >ase? electrolyte i">alances

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    16/34

    Nor"al Adult 9ater and .lectrolyte

    ReEuire"ent,electrolyte "eE5kg95day and ater cc5"*/

    150080!ater

    '?% ( 0?;'?0Cl

    '?0 ( '?%'?* ( '?1Mg

    '?1 ( )?)'?*Ca

    '?% ( *?)'?0 ( '?&:

    '?%(0?;'?0Na

    $sual needsMini"al needsCo"ponent

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    17/34

    0 G ) ( ) H )lukosa G le"ak

    ): "eE5kg5hari

    ) (*Na "eE5kg5hari

    ) )?&AsBA"ino5prot

    r5kg5hari

    *& 0' ,kritis/

    0' &'

    .nergi :cal5kg5hari

    *& 0' ,kritis/

    0' &'

    Air cc5kg5hari

    u"lahSu>strat nutrisi

    Maintenance

    fluid5electrolytereEuire"ents

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    18/34

    Co"position of Maintenance Fluid

    Type fluid Na Cl : Ca Mg lactate Sugar Tutofusin 42S )'' 8' )7 1 ; 075acetate &'5sor>itol

    :a.n Mg0 &' &' *' ( ( *' )''

    :a.n 0 &' &' *' ( ( *' *%

    :a.n 0A ;' &' )' ( ( *' *%

    R! )0) ))* 1 1B& ( *7 (

    :a.n ) 07B& 07B& ( ( ( ( 0%B&

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    19/34

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    20/34

    .lectro(neutrality

    In aEueous solutionthe su" of all negatively charge

    ion "ust eEual the su" of all positively charged ion

    In pure aterG the concentration of =

    @

    < =C40(

    In plas"aG other charged ion present also have an

    effect on the relative proportion of =@and =C40(

    These other charged "olecule , hich affect the

    dissociation of ater to give =@/independentvaria>le ,SID? AT4T? 2aC4*/

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    21/34

    " #aria$le

    %la&'a pH or H*

    +ndependent

    #aria$le

    Steart 2AB Can 2hysiol

    2har"acol ;)G)111()1;)?

    )870B

    ,ependent

    #aria$leJ

    pCO" S+, - ./O/ pH CO- H- OH- .- .H HCO-

    H"0 CO" H"CO H HCO-

    ./O/ .

    -

    .H(2a3Ca) ( Cl- lactate )

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    22/34

    a">legra"

    2a

    140

    KK++ 44

    CaCa++++

    MgMg++++

    Cl-

    102

    HCO-

    "4

    3./+O2 .2+O2

    S+,

    S/RO2 +O2 ,+ERE2CE

    A- 42A- 42

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    23/34

    NaNa NaNa NaNa

    K K KHCO3

    ClCl ClCl ClCl

    HCO3HCO3SID

    Normal Acidosis Alkalosis

    !ea6 acid i'$alance

    ( al$u'in or pho&phate )

    AlbAlbAlbAlbAlbAlb

    SID

    SID

    AlkalosisAlkalosis

    hypoalbumin/hypoalbumin/

    phosphatphosphat

    A!i"osis --#A!i"osis --#

    Hyp$p$otin /Hyp$p$otin /

    hyp$albuminhyp$albumin

    o$ phosphato$ phosphat

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    24/34

    Rule& o7 i&olated a$nor'alitie& in &tron ion

    di77erence (S+,) and total concentration o7 !ea6

    .cid

    S+,9./O/ +&olateda$nor'alitie&

    Re&ult

    SID Increase Meta>olic alkalosis

    SID Decrease Meta>olic acidosis

    AT4T Increase Meta>olic acidosis

    AT4T Decrease Meta>olic alkalosis

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    25/34

    2a: 140 'E;9 8S+, > 8 = : al6alo&i&= : al6alo&i&

    Contracted alkalosisContracted alkalosis

    2las"a 2las"a

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    26/34

    Na@ < )1' ".E5!

    Cl( < )'* ".E5!

    SID < 07 ".E5!

    )1'5* < %' ".E5!

    )'*5* < &) ".E5!

    SID < )8 ".E5!

    ) liter * liter

    !./ER E?CESS

    1

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    27/34

    Na@< )1' ".E5!

    Cl(< )'* ".E5!

    SID < 07 ".E5!

    Na@< )&1 ".E5!

    Cl(< )&1 ".E5!

    SID < ' ".E5!) liter ) liter

    2!ASMA @ NaCl 'B8-

    SID G 07

    2las"a NaCl 'B8-

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    28/34

    * liter

    =yperchlore"ic acidosis after NaCl 'B8-

    infusion

    :

    SID G )8 acidosis

    2a: (140154)9" 'E;9

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    29/34

    2a: 140 'E;9ase >alance

    Type of fluidFor volu"e effect

    Maintenance All ill influence acid >ase and electrolyte

    >alance

  • 7/25/2019 Aspect to Consider in Fluid Therapy

    34/34